Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1

Conditions

Breast Neoplasms 40Breast Neoplasms, Male 12Urinary Bladder Neoplasms 5Stomach Neoplasms 5Rectal Neoplasms 5Pancreatic Neoplasms 5Inflammatory Breast Neoplasms 5Esophageal Neoplasms 5Endometrial Neoplasms 5Colonic Neoplasms 5Carcinoma, Non-Small-Cell Lung 5Neoplasms 4Uterine Cervical Neoplasms 3Urethral Neoplasms 3Thyroid Neoplasms 3Salivary Gland Neoplasms 3Prostatic Neoplasms 3Lung Neoplasms 3Gallbladder Neoplasms 3Colorectal Neoplasms 3Carcinoma, Renal Cell 3Carcinoma, Hepatocellular 3Bile Duct Neoplasms 3Vulvar Neoplasms 2Vipoma 2Vaginal Neoplasms 2Unspecified Adult Solid Tumor, Protocol Specific 2Thyroid Carcinoma, Anaplastic 2Thyroid Cancer, Papillary 2Testicular Neoplasms 2

Interventions

Doxorubicin 4pazopanib 2cixutumumab 2Radiotherapy 2Ifosfamide 2sapanisertib 1romidepsin 1peposertib 1pembrolizumab 1pegfilgrastim 1liposomal doxorubicin 1ixabepilone 1interferon gamma-1b 1Trastuzumab 1Temozolomide 1Specimen Handling 1Sorafenib 1Radiation 1Molecular Diagnostic Techniques 1Microarray Analysis 1Magnetic Resonance Spectroscopy 1Interferon-gamma 1Imatinib Mesylate 1HhAntag691 1Filgrastim 1Everolimus 1Etoposide 1Diathermy 1Biopsy 12,2-dimethyl-N-(6-oxo-6,7-dihydro-5H-dibenzo(b,d)azepin-7-yl)-N'-(2,2,3,3,3-pentafluoropropyl)malonamide 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
NIH × Sarcoma, Synovial × Trastuzumab × Clear all
NCT00104949 2013-06-24

Trastuzumab in Treating Patients With Locally Advanced or Metastatic Synovial Sarcoma

National Cancer Institute (NCI)

Phase 2 Completed
40 enrolled
Sarcoma

Sarcoma, Sarcoma, Synovial

Data powered by HemOnc (CC BY 4.0) Colophon âš¡